Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760

Watchlist Manager
Shenzhen Mindray Bio-Medical Electronics Co Ltd Logo
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Watchlist
Price: 263.31 CNY -3.2% Market Closed
Market Cap: 318.7B CNY
Have any thoughts about
Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Write Note
Shenzhen Mindray Bio-Medical Electronics Co Ltd
/
Balance Sheet
/
Additional Paid In Capital

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Additional Paid In Capital
¥6.9B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Additional Paid In Capital
¥724m
CAGR 3-Years
66%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Additional Paid In Capital
¥2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
40%
J
Jafron Biomedical Co Ltd
SZSE:300529
Additional Paid In Capital
¥711.8m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Additional Paid In Capital
¥3.5B
CAGR 3-Years
53%
CAGR 5-Years
123%
CAGR 10-Years
17%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Additional Paid In Capital
¥13.9B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View

Market Cap
319.2B CNY
Industry
Health Care

Shenzhen Mindray Bio-Medical Electronics Co., Ltd., founded in 1991, has evolved into a leading global player in the medical device industry, with a compelling story of innovation and resilience at its core. Originating from the bustling tech hub of Shenzhen, the company specializes in developing and manufacturing high-quality medical equipment and solutions, particularly in the fields of imaging, in-vitro diagnostics, and patient monitoring. Mindray's commitment to advanced research and development has led it to achieve a strong competitive edge, enabling it to penetrate international markets and establish partnerships with healthcare providers across over 190 countries. With an unwavering focus on improving healthcare outcomes, Mindray is positioned not just as a manufacturer, but as a trusted partner in enhancing patient care worldwide. As an investor, you would be interested to know that Mindray's growth trajectory has been remarkable, characterized by steady revenue increases and robust profitability. The company's diversified product portfolio, including vital sign monitors, ultrasound systems, and laboratory solutions, addresses a wide array of healthcare needs, making it resilient to market fluctuations. Moreover, in response to the growing global emphasis on healthcare quality, Mindray continuously expands its innovations, investing significantly in R&D and leveraging advanced technologies like artificial intelligence. With a strong balance sheet and a commitment to ethical business practices, Mindray not only seeks to drive strong financial performance but also aims to foster a sustainable impact on global health, making it an attractive prospect for forward-thinking investors aiming to align their portfolios with socially responsible investments.

Intrinsic Value
360.5 CNY
Undervaluation 27%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
6.9B CNY

Based on the financial report for Jun 30, 2024, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Additional Paid In Capital amounts to 6.9B CNY.

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
-3%

Over the last year, the Additional Paid In Capital growth was -7%. The average annual Additional Paid In Capital growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been -5% over the past three years , -3% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.